AEGERION PHARMACEUTICALS INC has a total of 37 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2007. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ALIZE PHARMA SAS, CONNECTIVE THERAPEUTICS INC and SOPHERION THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | Japan | 3 | |
#5 | Mexico | 3 | |
#6 | Brazil | 2 | |
#7 | Canada | 2 | |
#8 | Australia | 1 | |
#9 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Electrical machinery and energy | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Electric discharge tubes | |
#6 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Erickson Mary | 10 |
#2 | Ghosh Soumitra S | 8 |
#3 | Guo Zijian | 8 |
#4 | Litzinger David C | 7 |
#5 | Sailstad Jeffrey | 6 |
#6 | Gelormini Ann | 5 |
#7 | Roth Jonathan David | 5 |
#8 | Mary Erickson | 5 |
#9 | Sasiela William J | 5 |
#10 | Wisler Gerald L | 3 |
Publication | Filing date | Title |
---|---|---|
WO2019032469A1 | Treatment of overweight and obesity associated with leptin deficiency | |
WO2018049424A1 | Methods of detecting anti-leptin neutralizing antibodies | |
BR102015025502A2 | lomitapide composition, tablet, lomitapide product, methods for analyzing a lomitapide sample composition and for determining an amount of an impurity in a composition sample | |
WO2010083279A2 | Methods for treating disorders associated with hyperlipidemia in a mammal | |
WO2010083280A2 | Methods for treating obesity and disorders associated with hyperlipidemia in a mammal | |
WO2008124384A2 | Combinations of mtp inhibitors with cholesterol absorption inhibitors or interferon for treating hepatitis c |